Enzymatic action of human glandular kallikrein 2 (hK2) substrate specificity and regulation by Zn2+ and extracellular protease inhibitors

European Journal of Biochemistry

Volumn 262, Issue 3, 1999, Pages 781-789

  Lövgren, Janita ^a,b   Airas, Kalervo ^c   Lilja, Hans ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF TURKU   (Finland)

^c NONE

Author keywords

Kallikrein; Prostate; Serpin; Substrate specificity; Zinc

Indexed keywords

ENZYME PRECURSOR; FIBRONECTIN; PROSTATE SPECIFIC ANTIGEN; PROTEINASE INHIBITOR; SERINE PROTEINASE; TISSUE KALLIKREIN; UROKINASE; ZINC;

ARTICLE; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME PURIFICATION; ENZYME SPECIFICITY; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; SEMINAL PLASMA; SEQUENCE HOMOLOGY;

BINDING SITES; EXTRACELLULAR MATRIX PROTEINS; GONADAL STEROID HORMONES; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; KALLIKREINS; KINETICS; MALE; PEPTIDES; PROTEASE INHIBITORS; SEMINAL PLASMA PROTEINS; SEMINAL VESICLE SECRETORY PROTEINS; SERPINS; SPERMATOZOA; SUBSTRATE SPECIFICITY; TISSUE KALLIKREINS; ZINC;

EID: 0343910900     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00433.x     Document Type: Article

References (58)

1. 1. Clements, J.A. (1989) The glandular kallikrein family of enzymes: tissue-specific expression and hormonal regulation. Endocrinol Rev. 10, 393-419.
2. 2. Drinkwater, C.C., Evans, B.A. & Richards, R.I. (1988) Kallikreins, kinins and growth factor biosynthesis. Trends Biochem. Sci. 13, 169-172.
3. 3. Lövgren, J., Valtonen-André, C., Marsal, K., Lilja, H. & Lundwall, Å. (1999) Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids. J. Androl. 20 (in press).
4. 4. Schedlich, L.J., Bennetts, B.H. & Morris, B.J. (1987) Primary structure of a human glandular kallikrein gene. DNA 6, 429-437.
5. 5. Clements, J.A., Mukthar, A., Verity, K., Pullar, M., McNeill, P., Cummins, J. & Fuller, P.J. (1996) Kallikrein gene expression in human pituitary tissue. Clin. Endcrinol. 44, 223-231.
6. 6. Hsieh, M.-L., Charlesworth, C., Goodmanson, M., Zhang, S., Seay, T., Klee, G.G., Tindall, D.J. & Young, C.Y.F. (1997) Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast camcer cell line T47-D. Cancer Res. 57, 897-899.
7. 7. Lövgren, J., Piironen, T., Övermo, C., Dowell, B., Karp, M., Pettersson, K., Lilja, H. & Lundwall, Å. (1995) Production of recombinant PSA and hK2 and analysis of their immunologic cross-reactivity. Biochem. Bioph. Res. Co. 213, 888-895.
8. 8. Piironen, T., Villoutreix, B.O., Becker, C., Hollingsworth, K., Vihinen, M., Bridon, D., Qiu, X., Rapp, J., Dowell, B., Lövgren, T., Pettersson, K. & Lilja, H. (1998) Determination and analysis of antigenic epitopes of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling. Protein Sci. 7, 259-269.
9. 9. Corey, E., Buhler, K.R. & Vessella, R.L. (1997) Cross-reactivity of ten anti-prostate-specific antigen monoclonal antibodies with human glandular kallikrein. Urology 50, 567-571.
10. 10. Piironen, T., Lövgren, J., Karp, M., Eerola, R., Lundwall, Å., Dowell, B., Lövgren, T., Lilja, H. & Pettersson, K. (1996) Immunofluorometric assay for the sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum. Clinical Chem. 42, 1034-1041.
11. 11. Kwiatkowski, M., Recker, F., Piironen, T., Pettersson, K., Otto, T., Wernli, M. & Tscholl, R. (1998) In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic 'gray zone' of total PSA 4-10 ng/ml. Urology 52, 360-365.
12. 12. Recker, F., Kwiatkowski, M.K., Piironen, T., Pettersson, K., Lümmen, G., Wernil, M., Wlefelspütz, J., Goepel, M., Huber, A. & Tscholl, R. (1998) The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma. Cancer 83, 2540-2547.
13. 13. Reference withdrawn.
14. 14. Deperthes, D., Chapdelaine, P., Tremblay, R.R., Brunet, C., Berton, J., Hébert, J., Lazure, C. & Dubé, J.Y. (1995) Isolation of prostalic kallikrein hK2, also known as hGK-1, in human seminal plasma. Biochim. Biophys. Acta 1245, 311-316.
15. 15. Frenette, G., Deperthes, D., Tremblay, R.R., Lazure, C. & Dubé, J.Y. (1997) Purification of enzymatically active kallikrein hK2 from human seminal plasma. Biochim. Biophys. Acta 1334, 109-115.
16. 16. Bourgeois, L., Brillard-Bourdet, M., Deperthes, D., Juliano, M.A., Juliano, L., Tremblay, R.R., Dubé, J.Y. & Gauthier, F. (1997) Serpin-derived peptide substrates for investigating the substrate specificity of human tissue kallikreins hK1 and hK2. J. Biol. Chem. 272, 29590-29595.
17. 17. Christensson, A.,Laurell, C.-B. & Lilja, H. (1990) Enzymatic activity of prostate-specific antigen and it's reactions with extracellular serine proteinase inhibitors. Eur. J. Biochem. 194, 755-763.
18. 18. Malm, J., Hellman, J. & Lilja, H. (1997) Mapping of the unique enzyme characteristics of PSA. J. Urology 157 (Suppl.), 345.
19. 19. Denmeade, S.R., Lou, W., Lövgren, J., Malm, J., Lilja, H. & Isaacs, J.T. (1997) Specific and efficient substrates for assaying the proteolytic activity of prostate-specific antigen. Cancer Res. 57, 4924-4930.
20. 20. Coombs, G.S., Bergstrom, R.C., Pellequer, J.-L., Baker, S.I., Navre, M., Smith, M.M., Tainer, J.A., Madison, E.L. & Corey, D.R. (1998) Substrate specificity of prostate-specific antigen (PSA). Chem. Biol. 5, 475-488.
21. 21. Cohen, P., Graves, H.C.B., Pheel, D.M., Kamarei, M., Giudiee, L.C. & Rosenfeld, R.G. (1992) Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin. Endocr Metab. 75, 1046-1053.
22. 22. Iwamura, M., Hellman, J., Cockett, A., Lilja, H. & Gershagen, S. (1996) Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen. Urology 48, 317-325.
23. 23. Lilja, H. (1985) A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J. Clin. Invest. 76, 1899-1903.
24. 24. Robert, M. & Gagnon, C. (1996) Purification and characterization of the active precursor of a human sperm motility inhibitor secreted by the seminal vesicles: identity with semenogelin. Biol. Reprod. 55, 813-821.
25. 25. Deperthes, D., Frenetic, G., Brilliard-Bourdet, M., Bourgeous., L., Gauthier, F., Tremblay, R.R. & Dubé, J.Y. (1996) Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesicle proteins after ejaculation. J. Androl. 17, 659-665.
26. 26. Lövgren, J., Rajakoski, K., Karp, M., Lundwall, Å. & Lilja, H. (1997) Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2. Biochem. Bioph. Res. Co. 238, 549-555.
27. 27. Kumar, A., Mikolajczyk, S.D., Goel, A.S., Millar, L.S. & Saedi, M.S. (1997) Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. Cancer Res. 57, 3111-3114.
28. 28. Mikolajczyk, S.D., Millar, L.S., Marker, K.M., Grauer, L.S., Goel, A., Cass, M.M.J., Kumar, A. & Saedi, M.S. (1997) Ala217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2. Eur. J. Biochem. 246, 440-446.
29. 29. Takayama, T.K., Fujikawa, K. & Davie, E.W. (1997) Characterization of the precursor of prostate-specific antigen. J. Biol. Chem. 272, 21582-21588.
30. 30. Frenette, G., Tremblay, R.R., Lazure, C. & Dube, J.Y. (1997) Prostatic kallikrein hK2 hut not prostate-specific antigen (hK3) activates single-chain urokinase-type plasminogen activator. Int. J. Cancer 71, 897-899.
31. 31. Oesterling, J.E., Jacobsen, S.J., Klee, G.G., Pettresson, K., Piironen, T., Abrahamsson, P.-A., Stenman, U.-H., Dowell, B., Lövgren, T. & Lilja, H. (1995) Free, complexed and total serum PSA: the establishment of appropriate reference ranges for their concentratios and ratios. J. Urology. 154, 1090-1095.
32. 32. Malm, J., Hellman, J., Magnusson, H., Laurell, C.-B. & Lilja, H. (1996) Isolation and characterization of the major gel proteins in human semen, semenogelin I and semenogelin II. Eur. J. Biochem. 238, 48-53.
33. 33. Hermans, J.M. & Stone, S.R. (1993) Interaction of activated protein C with serpins. Biochem. J. 295, 239-245.
34. 34. Hermans, J.M., Jones, R. & Stone, S.R. (1994) Rapid inhibition of the sperm protease acrosin by protein C inhibitor. Biochemistry 33, 5440-5444.
35. 35. Lilja, H., Abrahamsson, P.-A. & Lundwall, Å. (1989) Semenogelin, the predominant protein in human semen. J Biol. Chem. 264, 1894-1900.
36. 36. Lilja, H. & Lundwall, Å. (1992) Molecular cloning and epididymal and seminal vesiculr transcripts encoding a semenogelin-related protein. Proc. Natl Acad. Sci. USA. 89, 4559-4563.
37. 37. Pattison, S.E. & Dunn, M.F. (1975) On the relationship of zinc ion to the structure and function of the 7S nerve growth factor protein. Biochemistry 14, 2733-2739.
38. 38. Brillard-Bourdet, M., Moreau, T. & Gauthier, F. (1995) Substrate specificity of tissue kallikreins: importance of an extended interaction site. Biochim. Biophys. Acta 1246, 47-52.
39. 39. Devi, L. (1991) Consensus sequence for processing of peptide precursors at monobasic sites. FEBS Lett. 280, 189-194.
40. 40. Steiner, D.F., Smeekens, S.P., Ohagi, S. & Chan, S.J. (1992) The new enzymology of precursor processing endoproteases. J. Biol. Chem. 267, 23435-23438.
41. 41. Nakayama, K., Watanabe, T., Nakagawa, T., Kim, W.-S., Nagahama, M., Hosaka, M., Hatsuzawa, K., Kondoh-Hashiba, K. & Murakami, K. (1992) Consensus sequence for precursor processing at mono-arginyl site. J. Biol. Chem. 267, 16335-16340.
42. 42. Robichon, A. & Kuks, P. (1991) Proteolysis in rat hypothalamic neurosecretory granules: characterization of an alpha-chymotrypsin-like activity in the pathway of intracellular processing of prohormones. Endocrinology 128, 1974-1980.
43. 43. Bresnahan, P.A., Leduc, R., Thomas, L., Thorner, J., Gibson, H.L., Brake, A.J., Barr, P.J. & Thomas, G. (1990) Human fur gene encodes a yeast KEX2-like endoprotease that cleaves proβ-NGF in vivo. J. Cell. Biol. 111, 2851-2859.
44. 44. Ohlsson, K., Bjartell, A. & Lilja, H. (1995) Secretory leucocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization. J. Androl. 16, 64-73.
45. 45. Laurell, M., Christensson, A., Abrahamsson, P.-A., Stenflo, J. & Lilja, H. (1992) Protein C inhibitor in human body fluids. J. Clin. Invent. 89, 101-109.
46. 46. Grauer, L.S., Finlay, J.A., Mikolajczyk, S.D., Pusateri, K.D. & Wolfert, R.L. (1998) Detection of human glandular kallikrein, hK2, as its precursor form and in complex with protease inhibitors in prostate carcinoma serum. J. Androl. 19, 407-411.
47. 47. Espana, F., Estellés, A., Fernandez, P.J., Gilabert, J., Sânchez-Cuenca, J. & Griffin, J. (1993) Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasma. Thromb. Haemostasis 70, 989-994.
48. 48. Zheng, X., Geiger, M., Ecke, S., Bielek, E., Donner, P., Eberspächer, U., Schleuning, W.-D. & Binder, B.R. (1994) Inhibition of acrosin by protein C inhibitor and localization of protein C inhibitor to spermatozoa. Am. J. Physiol. 262, C466-C472.
49. 49. Espana, F., Fink, E., Sanchez-Cuenca, J., Gilabert, J., Estelles, A. & Witzgall, K. (1995) Complexes of tissue kallikrein with protein C inhibitor in human semen and urine. Eur. J. Biochem. 234, 641-649.
50. 50. Christensson, A. & Lilja, H. (1994) Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen. Eur. J. Biochem. 220, 45-53.
51. 51. Ecke, S., Geiger, M., Resch, I., Jerabek, I., Sting, L., Maier, M., Binder, B. & R. (1992) Inhibition of tissue kallikrein by protein C inhibitor. J. Biol. Chem. 267, 7048-7052.
52. 52. Cunningham, B.C., Mulkerrin, M.G. & Wells, J.A. (1991) Dimerization of human growth hormone by zinc. Science 253, 545-253.
53. 53. Kavanagh, J.P. (1985) Sodium, potassium, calcium, magnesium, zinc, citrate and chloride content of human prostatic and seminal fluid. J. Reprod. Fert. 75, 35-41.
54. 54. Kavanagh, J.P. (1983) Zinc binding properties of human prostatic tissue, prostatic secretion, and seminal fluid. J. Reprod. Fert. 68, 359-363.
55. 55. Villoutreix, B.O., Getzoff, E.D. & Griffin, J.H. (1994) A structural model for the prostate disease marker human prostate-specific antigen. Protein Sci. 3, 2033-2044.
56. 56. Frenette, G., Tremblay, R.R. & Dube, J.Y. (1989) Zinc binding to major human seminal coagulum proteins. Arch. Androl. 23, 155-163.
57. 57. Gyorkey, F., Min, K.W., Huff, J.A. & Gyorkey, P. (1967) Zinc and magnesium in human prostate gland: normal, hyperplastic, and neoplastic. Cancer Res. 27, 1348-1353.
58. 58. Feustel, A., Wennrich, R., Steininger, D. & Klauss, P. (1982) Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH). Urol. Res. 10, 301-303.